Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diabulimia and Type 1 Diabetes: An Unknown and Emerging Problem.
Rivolta B, Masserini B, Bernardi I, Camera A, Liboà F, Solerte SB, Cerabolini C, Cerutti N. Rivolta B, et al. Among authors: cerutti n. Endocr Metab Immune Disord Drug Targets. 2024 Apr 30. doi: 10.2174/0118715303314948240419060714. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38693738
Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study.
Bogliolo L, Cereda E, Klersy C, Stefano L, Lobascio F, Masi S, Crotti S, Bugatti S, Montecucco C, Demontis S, Mascheroni A, Cerutti N, Malesci A, Corrao S, Caccialanza R; NUTRI-COVID19 Collaborative Working Group. Bogliolo L, et al. Among authors: cerutti n. Front Nutr. 2022 Jul 5;9:934258. doi: 10.3389/fnut.2022.934258. eCollection 2022. Front Nutr. 2022. PMID: 35866079 Free PMC article.
Nutraceuticals and Oral Supplements in Cancer Prevention: A Narrative Review.
De Pergola G, Marucci S, Corbo F, Almerighi G, Cerutti N, Triggiani V, De Vito D, Castellana F, Zupo R. De Pergola G, et al. Among authors: cerutti n. Endocr Metab Immune Disord Drug Targets. 2023;23(8):1021-1031. doi: 10.2174/1871530322666220527152414. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35638269 Review.
Eating Disorders in the Time of the COVID-19 Pandemic: A Perspective.
Marucci S, Almerighi G, Cerutti N, Corbo F, Zupo R, De Iaco G, Lisco G, Triggiani V, De Pergola G. Marucci S, et al. Among authors: cerutti n. Endocr Metab Immune Disord Drug Targets. 2023;23(2):123-128. doi: 10.2174/1871530322666220422104009. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35466887
46 results